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Susceptibility to vancomycin, teicoplanin, penicillin, streptomycin 
and gentamicin was determined using three methods: microdhtion, 
disk diffusion and Etest. The production of beta-lactamase was 
assessed with nitrocefin disks. Typing was pedormed by PCR. 
Results: All strains were resistant to vancomycin, teicoplanin, 
penicillin, streptomycin HL and gentamicin HL. The pheno- and 
genotypic analyses of all VREM isolates indicated the presence of the 
uanA genotype. VREM were isolated from blood samples (lo), 
sputum (3). stool (29), urine (3). skin (2), vagina (1) and throat (1). 
Eight patients were infected (positive blood cultures) and 21 were 
colonized (positive stool cultures). 
Conclusions: We describe the first outbreak due to VREM in a 
hematologic unit in Poland. VREM presented a new therapeutic 
problem in hematologic patients, especially after bone marrow trans- 
plantation. However, their true clinical significance in our patients 
was not clear. 
I PI 461 Chloramphenicol treatment for vancomycin- 
resistant Enterococcus faecium (VREF) 
bacteremia 
J.C. Ricaurte, G.S. Turett, J.W. Kislak, Saint Kncents Hospital, 
Infectious Disease, New York, USA 
The incidence of VREF bacteremia has been steadily increasing. 
VREF infections are challenging, since resistance to ampicillin and 
aminoglycosides is usually present as well. Patients with VREF 
bacteremia frequently have significant co-morbidities and a high 
mortality rate. We recently had success in treating sustained VREF 
bacteremias with chloramphenicol. 
Our hospital has a large oncology service. Between January and 
May 1998, six episodes of sustained VREF bacteremia occurred in 
five cancer patients. Mean age was 55 years; three were neutropenic 
at the time of bacteremia. VREF were isolated in pure culture in 
all patients. All isolates were resistant to vancomycin, ampicillin 
and aminoglycosides but were susceptible to chloramphenicol. 
Chloramphenicol dosing ranged from 750 mg to 1 g IV q6h. Four 
of six episodes of VREF bacteremia occurred in patients with chronic 
indwelling central venous catheters (one patient also had a biliary 
stent). These devices were left in place: the only intervention was 
instituting chloramphenicol therapy. 
In four episodes, patients received chloramphenicol for 10-21 
days, and had clinical and microbiological responses. Another patient 
who received 5 days of chloramphenicol had a microbiological 
response but died of his underlying malignancy. The last patient had 
a sustained VREF bacteremia over 3 days and died within 48 h of 
starting chloramphenicol. 
In summary, five of six episodes of VREF bacteremia in severely 
ill cancer patients responded clinically and/or microbiologically to 
chloramphenicol. These data suggest that chloramphenicol may be 
useful in treating infections with this highly resistant organism. 
v1 Vancomycin-resistant enterococci (VRE): a 
point prevalence study of intestinal 
colonization in hospitalized patients 
E. Cercenado, L. Alcala, B. Padilla, F. Garcia-Garrote, L. Tonnes, 
E. Bouza. Hospital General Liniuersitario ‘Gregorio Maranon ’, Madrid, 
Spain 
In our hospital the incidence of VRE from 1988 to 1998 has oscil- 
lated between 0.5% and 0.7%. The routine isolation of VRE in 
microbiology laboratories probably underscores the rate of intestinal 
colonization with VRE. 
Objectives: To investigate the prevalence of fecal carriage ofVRE 
among all patients admitted to our hospital. 
Materials and methods: We carried out a point prevalence 
culture survey in a single day by culturing fecal samples of all hospi- 
talized patients in M-Enterococcus agar media supplemented with 
vancomycin (6 mg/L). Susceptibilities to vancomycin and teicoplanin 
were determined by the microdilution method (NCCLS). 
Results: At the time of the study, the hospital occupation was 
1274 beds, and 844 patients (66%) were allowed to provide a fecal 
sample. Forty of the 844 patients (4.7%) were found to be VRE 
carriers. Thirty-one strains were Enteroroccus faecium, three were 
Enterococcus faecalis, three were Enteroroccur durans, and three were 
Enferococcns casseliJ¶pauus. We obtained 83% VanA (30 (94%) E.faecium, 
three E .  duranr, and one E.faecalis), 5% VanB (two E &ecalis), and 
seven VanC (three E .  rassel&uus). An epidemiologic study revealed 
that although VRE colonization was more frequent among 
vancomycin-treated patients (OR= 1.98) and those at ICUs 
(OR= 1.70). a significant associated risk factor was duration of hospi- 
talization (p< 0.05). 
Conclusions: A low rate of colonization with VRE was detected 
in our institution. N o  association was found between the use of 
vancomycin and the isolation of VRE. 
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Ip1481 Humoral and cellular immune responses of 
mice following oral immunization with cholera 
toxin 
G.I. Vasilieva, V.N. Kozlovsky. Research Institutefor H a p e  Control, 
Rostou-on-Don, Russia 
Objectives: Humoral, cellular and local immune responses follow- 
ing oral immunization of BALB/c mice with cholera toxin (CT) 
were investigated. 
Methods: The study was conducted with use of ELSA and the 
indirect immunofluorescent method. 
Results: Oral administration of C T  provided the certain eleva- 
tion in Peyer’s patches and lamina propria of an amount of B- 
lymphocytes bearing membrane immunoglobulins of various 
isotypes and increase of CT-specific lgA, IgM (especially) and lgG1 
titers in gastrointestinal lavage fluids and fecal extracts. In sera, eleva- 
tion mainly in 1gG1 antibody titers and moderate increases in 
amounts of IgA, IgGz,, IgGzb and IgGi were observed. These find- 
ings testify to the advantages of oral CT administration for induction 
of secretory IgA production. The observable changes in humoral 
immune response were accompanied by elevated secretion of IL-4, 
IL-5 and IL-6 on a background of moderate IL-2 production, indi- 
cating involvement of these three cytokines in B-cell maturation 
processes. Parenteral application of C T  was accompanied by not only 
moderate secretion of IL-2. but also an insignificant increase of IL-6 
production and absence of stimulation of interferon-gamma produc- 
tion. Probably, these findmgs indicate the insufficiency of the growth 
factors for adequate differentiation of not only T-lymphocytes but 
also B-lymphocytes. 
Conclusions: C T  used orally stimulates the creation of rather 
intense local immunity and development of the certain systemic 
response which is not accompanied by significant immunodeficiency 
as with parenteral administration. 
Abstracts 1 2 5  
(p149( Recombinant interferon-gamma as a 
therapeutic immunomodulator in tularemia 
V.N. Kozlovsky, G I .  Vasilieva. Research Inrtitnrejir Pla'qire Control, 
Rosfov-on-Don, Rirssia 
Objectives: The influence of recombinant interferon-gamma (IFN- 
gamma) as a therapeutic agent for mice tularemia was investigated. 
Methods: Proliferative activity of lymphocytes was evaluated in 
the blast transformation test. Membrane receptors and cytokines was 
determined with the use of inonoclonal antibodies in the iininuno- 
fluorescence test. 
Results: IFN-gamma is one of the major endogenic immuno- 
niedidtors involved in processes of attraction and activation of 
mononuclear phagocytes. It was shown that the tulareniic infection 
stimulated in mice is accompanied by essential suppression of IL-2 
production, IL-2-receptor expression and IFN-gamma production. 
As a consequence, decreases in the lymphocyte proliferative activity 
and suppression of phagocytosis are observed. The administration of 
recombinant IFN-gamma (100 000-500 000 ME/kg for 24 h prior 
to inoculation and on each consequent fourth day) provided an esseii- 
tial decrease in the immune system depression. At this time the reduc- 
tion in generation and function of the suppressor T-lymphocytes 
(CD8+) was observed. It was reflected in amplification of the prolif- 
erative response of tularemia-primed lymphocytes to heterologous 
antigens. Furthermore, augmentation of microbicidal activity of 
niacrophages, and production of TN17-alpha and TNF-alpha recep- 
tor expression, were shown. 
Conclusions: Probably, IFN-gamnia has the potential for use in 
the treatment of tularemia as immunomodulator in the complex ther- 
apy of this infection. 
Influenza in Poland in the epidemic season 
1997198 
L.B. Brydak, M. Machala. National IP$UFEZ& Center WHO, 
Departzr~nt of Virolo'qy, National Institute of Hyzienc, Warsaiq Poland 
Objectives: To assess the epidemiologic dnd virologic situation of 
influenza. 
Methods: Clinical specimens were collected to isolate influenza 
viruses. Isolation was carried out in 11-day-old chicken embryos. 
Type and subtype of isolated strains were determined by the heiiiag- 
glutinin inhibition test performed with the reference antisera and 
0.5% chicken red blood cells. The epideniiologic data were obtained 
from the Department of Epidemiology, National Institute of 
Hygiene, Warsaw. 
Results: The number of influenza and influenza-like cases 
between 1 October 1997 and 30 April 1998 amounted to 755 768 
(the incidence per 100 000 was 1955.4). In October, the number of 
cases amounted to 735, and in November and December it was 1438 
and 1684 respectively In January 1998 and in February, the nuinber 
of cases increased to 6484 and 9838 respectively. The highest 
influenza activity was observed in March (408 058 cases) and April 
1998 (327 531 cases). The number ofcases registered in 1997/98 was 
2.1 times lower when compared with the previous epidemic season. 
In January 1998 three strains of influenza virus were isolated from 
patients aged 5 months, 11 yearc and 17 years and were determined 
as a subtype A (H3N2). Two isolates were antigrnically similar to 
A/Nanchang/933/95, i.e. the strain recommended by the W H O  for 
the epidemic season 1997198, while one strain was closely related to 
A/Johannesburg/33/94. 
Conclusions: The number of influenza cases in 1997/98 was 
lower in comparison with 1996/97. The highest influenza activity 
was observed in March and April, while in 1996/97, the highest 
artivity was observed in January atid February. Two of rhrce isolated 
viruses were, as in other countries, antigenically close to the vaccine 
strain A/NancIiang/Y33/95. The iwlation of a \train similu to 
A/Johannesburg/33/94 is unusual, considering the f~xx that in 
Europe A/Wuhan/359/95-like viruses (including A/Nmchang/ 
933/95) and A/Sydney/5/97-like viruses were predonunant during 
this time. 
Humoral immune response to influenza 
vaccination in patients with renal failure 
L.B. Brydak', M. Blaini', M. Machala'. B. Leszczynska?, M. 
Sieniawska. 'National blflrrrnza Center WHO, Drpnrtnieiir of Virolcyy, 
hk'nriorzol Institute of Hyxiene, 'Departnirrrt of Pedinrrio and ~ % p / i r o h y ) ~ ,  
Lh7iwrsity Clddren's Hospifal, Warsaw, Poland 
Objectives: To assess the hunioral iniiiiuiie responre to influenza 
vaccination in patients with renal failure. 
Methods: The study group consisted of 26 patwnts ngrd 5-19 
with renal failure. In autumn 1995 they received a single 0.5-mL 
dose of split influenza vaccine (Vaxigrip, I'asteur Mericux). 
Antihemagglutinin (HI) and aiitineuraiiiiiiidase (NI) antibody titc'i-s 
were determined before imniunization and then 1, 3 and 6 iiiontht 
after immunization by heniagglutinin inhibition test and neuranuni- 
dase inhibition test. The same procedures were carricd out iii the 
control group of 26 healthy non-vaccinated children. 
Results: One iiionth after vaccination, mean fold increases (MFIs) 
of antibody titers ranged from 4.9 to 7.6 for HI antibodics, whilc for 
NI antibodies they were between 3.6 and 7.2. Three niiinths nftcr 
iniiiiuiiizatioii, a further increase of HI and NI antibody levels w-is 
noted, and MFI\ ranged froni 6.5 to 11.9 and from 12.1 to 1.58 
respectively Six months after immunization, geometric iiic'aii titers 
(GMTs) of H1 antibodies were slightly lower when rompred with 
the values recorded 3 months after vaccination, but not lowrr than 
those observed after 1 month. In the case of NI antibodies the hi& 
est CMTF were found 6 months after vaccination and they ranged 
from 21.1 to 25.9. After vaccination the highot protection raet 
amounted to 61.5% for heinagglutinin H I and HB, and .50% for 
hemagglutinin H3. The highest response rates amounted to 57.7% 
for H1 and 50%) for H3 and HB. 
Conclusions: The results obtained in the present study confirin 
the ininiunogenicity of split influenza vaccine in patients with rcnal 
failure. 
Low measles antibody levels are associated 
with class I HLA homozygosity in Hispanics 
T. Grizzard, G. Poland, R. Jacobson, R. Vierkant. .Vhlayo bhciirri 
Research Gronp, i2;layo Chic, Rochester, MY USA 
Background: The human leukocyte mtigen (HLA) genes bind 
peptide antigens and display antigenic peptides to T-celli. The HLA 
genes may be considered to be immune response gencs. A previour 
seroprevalence study in a Caucasian population showed th:~t poor 
measles vaccine response (very low levels of nie'isles antibody after 
ininiunization) was bignificantly associated with class I homozygo- 
ity, The purpose of this study was to deterniine if class 1 HLA 
homozygosity was also.associated with low levels of measles antibody 
in a Hispanic population-whether due to vaccine or wild virus  
infection. 
Methods: Two hundred and sixtynine Hispanic individuals were 
enrolled. All individuals were o f  Mexican descent. Blood wa> dr.wi1 
from each subject and tested for meask-specific wholc virus mti- 
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body IgG EIA (BioWhittaker, Walkersville, MD) in duplicate. Class 
I HLA typing was done by serologic microlymphocytotoxicity. 
Results: Twenty-six per cent (n=70) of the subjects had received 
measles vaccine, and 74% (n=  199) had a history of measles infection. 
Ninety-seven per cent of the subjects were seropositive against 
measles. From the spectrum of all antibody levels, the top 5% of all 
antibody levels were termed high-responders, and the bottom 5% 
were classified as low-responders. The low-responders had a higher 
rate of class I HLA homozygosity than did the high-responders 
(69.2% versus 30%, p=O.O5). We also found a trend toward a higher 
rate of HLA-C homozygosity between low- and high-responders 
(78% versus 25%, respectively; p=NS); however, we only had 15% 
power to detect a difference at this locus. 
Conclusions: As in Caucasians, class I HLA homozygosity in 
Hispanics is also associated with low levels of measles antibody after 
exposure to vaccine virus or wild virus. Class I HLA homozygosity 
limits the diversity of measles-derived peptides presented to T-cells, 
resulting in diminished circulating humoral antibody responses 
Association of HLA-DQB 1 alleles and antibody 
(Ab) levels after measles immunization: 
preliminary results 
I. Ovsyannikova, G. Poland, R. Jacobson, R. Vierkant, D. Shaid, S. 
Jacobsen. Mayo Clinic G Foundation, Rochester, MN, USA 
Objectives: The HLA class I1 DQBl gene encodes the R-chain of 
the DQ molecule and shows a high degree of polymorphism. 
Previous studies have shown associations of HLA-DQA1 alleles with 
Ab levels to measles vaccine (MV) virus; however, no information on 
the role of HLA-DQB1 alleles is available. We investigated the rela- 
tionship of the HLA-DQB1 alleles and MV-induced humoral Ab 
levels in US schoolchildren. 
Methods: To determine the HLA-DQB1 allele frequency distri- 
bution and homozygosity rates between MV non-responders (NRs) 
and hyper-responders (HRs), we performed DQBl typing by PCR- 
SSP on 81 N R  (IgG seronegative) and 87 H R  (upper 10th percentile 
of IgG levels of all subjects) schoolchildren immunized at age 15 
months with MMR-11. Levels of measles-specific IgG Ab were 
determined by a whole virus EIA (BioWhittaker, Walkersville, MD). 
Allele frequencies and homozygosity rates were compared using 
Pearson's chi-square statistic. 
Results: The overall allele frequency distribution between NRs 
and HRs was significantly different ( ~ ~ 0 . 0 2 7 ) .  Analysis of individ- 
ual allele frequencies between NRs and HRs revealed that MV NRs 
had an excess of DQB1*0301 allele (23.5% versus 13.2%, p=0.015). 
In contrast, in HRs we observed an increased frequency of the alle- 
les DQB1'0602 and DQB1*0302 (16.7% versus 8.0%, p=0.0 17, and 
19.0% versus 9.9%, p=0.0 18, respectively). Overall, homozygosity 
rates between NRs and HRs were not significantly different 
@=0.69). However, analysis of homozygosity for individual alleles 
revealed that NRs were less likely to be homozygous for DQB*0302 
than HRs (0% versus 5.8%, p=O.O28). Homozygous NRs were more 
likely to carry the DQB1'0301 allele compared to HRs (11.1% 
versus 2.3'36, p=0.021). 
Conclusions: Our results suggest that certain HLA-DQBI alle- 
les may influence MV Ab levels and their role should be further 
examined. 
Tetanus immunity among Hispanic migrant 
agricultural workers in southeastern 
Minnesota, USA 
K.C. Reid, E.L. Berven, R.R. Gonzales, H.  Zarnhrano-Berg, 
R.R. Ledo, P.C. Wollan, R.M. Jacobson, G.A. Poland. Mayo Clinic 
and Foundation, Rockester, MN, CJSA 
Background Studies have shown that the incidence of tetanus is 
highest in Hispanic Americans. Since Hispanic migrant farmworkers 
(HMFs) may be at higher risk for exposure to tetanus because of their 
occupation, we investigated the level of immunity to tetanus in 
HMFs in southeastern Minnesota, USA. 
Methods: One hundred and nineteen HMFs (33% males, 67% 
females), ages ranging from 14 to 70, were enrolled. Control samples 
were obtained from banked sera of healthy volunteers from other 
concurrent non-tetanus vaccine trials. Subjects and controls were 
matched according to gender and age, as tetanus seroprotection is 
greater for men than for women in the USA and antibody levels wane 
with age. Levels of IgG anti-tetanus toxoid-specific antibody were 
determined for all serum samples using the Bindazyme enzyme 
inummoassay (The Binding Site, Birmingham, UK). Statistical analy- 
ses were performed using multiple logistic regression, paired t-test 
and the McNemar chi-squared test. 
Results: A coniparison of log-transformed continuous antibody 
levels of HMFs to controls showed that overall antibody levels were 
significantly lower for HMFs than for controls (0.3671 versus 1.1960; 
p=0.0001) .There were no significant differences between male 
HMFs and male controls (0.8831 versus 1.3384; p=0.0948), hut 
female HMFs had significantly lower antibody levels than female 
controls (0.1156 versus 1.1266; p=O.OOOl). When compared by age 
groups, female HMFs aged 20-39 years had significantly lower anti- 
body levels than age-matched female controls (0.0682 versus 0.9854; 
p=0.0003). Six (7.5%) female HMFs did not have protective anti- 
body levels (<0.15 IU/mL). 
Conclusions: Our study indicates that female HMFs have lower 
antibody levels than controls. This is especially true for those of child- 
bearing age. This is important, as their newborn children may he a t  
risk for neonatal tetanus. 
[m] lmmunogenicity and predictors of immune 
response to Hib protein conjugate vaccine in 
HIV-seropositive adults 
D.H. Dockrell', G.A. Poland, J.M. Steckelberg, P.C. Wollan, S.R. 
Strickland, C. Pomeroy'. 'Divisioris of Infectious Diseases, University of 
Shefield Medical School, Shefield, UK; 'University $Kentucky, USA, 
and Mayo Vaccine Research Group, Mayay0 Clinic, Rochester, MN, USA 
Background HIV-seropositive adults are at increased risk of respi- 
ratory tract bacterial infections, including Haemophilus injuenzae type 
b (Hib). Immunization against specific pathogens decreases this risk. 
Protein conjugate vaccines induce T-cell-dependent immune 
responses but their immunogenicity and predictors of immune 
response in HIV-positive adults require further study. 
Methods: We performed a prospective clinical trial of immune 
responsiveness to Hib immunization. One hundred and thirty-six 
HIV-seropositive adults received one of three protein conjugate Hib 
vaccines (PRP-D, Hh-OC, HbNOMP). Anti-polyribosylribitol 
phosphate (PRP) antibodies were measured at 0, 1, 3 and 12 months 
post-immunization by the Farr-type RIA method. Univariate 
logistic regression analysis was performed to identify predictors of 
immune response retrospectively. 
Results: Nnety-five per cent of subjects were male. The median 
age was 36 years (21-73), with a median baseline CD4 T-cell count 
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of 289/mL (0-928). One hundred and six (76%) were receiving anti- 
retroviral therapy Protective (> 1.0 mg/L) levels of anti-PKP were 
detected in 27% of individuals pre-immunization, 91% at 1 and 3 
months, and 79% at 12 months post-iiiimunization. In univariate 
analysis, low IgGz levels predicted a poor vaccine response at 1 and 
12 months (p<O.01 and 0.05, respectively) and low CD4 T-cell count 
predicted a poor response at 12 months (p<O.OI). Age, sex, anti- 
retroviral use and total IgG or lgGl levels were iiot predictive of 
iinniune response. 
Conclusion: While the cost-effectiveness of immunizing HIV- 
positive adults against Hib I S  a matter for debate, this study denion- 
strates that protein conjugate vaccines are immunogenic in this group. 
Pre-inimunization IgGz levels and CD4 T-cell counts are the best 
predictors of iiniiiune response. 
Ip1561 lmmunomodulatory effect of Bacteroides 
fragilis and B. thetaiotaomicron on the mouse 
macrophage cell line IC-21 
R. Schauiiiann, B. Haertel, N. Kleinkauf, M. Heiiiz. A.C. 
Rodloff. Institrite qf Medical Microbiology and Epidemi~ilu~qy cf Irijitiuirs 
Diseases, Ilnirsrsity i!f hip+<, LA@+, Germany 
Objectives: To study the influence of 5. fiagilis aiid 5. tlietaiornumi- 
trot1 on niotise macrophages (IC-21 cell line) with respect to the 
expression of IL-I I3 and IL-6 niRNA. 
Methods: IC-21-cells were incubated with different quantities of 
5. jiagilis or 5. thplaiotnornicrun, vital or inactivated by UV radiation. 
respectively. Moreover, IC-21 cells were incubated with B.-fia,qilis or 
B. f/rct~iotao~iiirr~iri, respectively and E. coli LPS (1 mg/L). Negative 
controls were run with untreated cells, and positive controls were ruu 
with E .  toli L.PS (1 mg/L). IL-lfl and IL-6 m R N A  were measured 
with PCK qualitatively and with HPLC semi-quantitatively. 
Results: niRNA for both cytokines was detected in all assays, 
including the controls. Vital as well as inactivated bacteria induced 
1L-113 and IL-6 m R N A  in a dose-dependent manner. However, the 
highest concentrations were iiiduced by 1 nlg/L E. roli LPS. With 
LPS co-stimulation. higher quantities of m R N A  were detected 
compared with the assays of  bacteria without LPS. There were no 
dose-dependent differences. Except for the IL-6 m R N A  in the assay 
with R. jiagrlrs, mRNA quantities were higher than those for thc 
controls with 1 mg/L E. coli LPS. 
Conclusions: Our  results are in contrast to earlier studies employ- 
ing bioassays and higher LPS concentrations. Further experiments are 
neccssary to reconcile these differences. 
[m Stimulation of phagocytic capacity of human 
polymorphonuclear leukocytes by a bacterial 
polysaccharide, levan 
A. Zilevica, I. Vim, R. Treimane, H. Grante, A. Karsakevich, S 
Gont.1. Latoiilrr University, R@, Latvia 
Objectives: To determine the potential iniinunoinodulating activ- 
ity of the bacterial polysaccharide levan. 
Methods: A levan-producing bacterium, Zynioinonas mobilis 
special strain 11 3 'S', was selected, producing in sucrose medium 
extracellular capsular poly-D-fructan with uniqae types of biiiding 
of B-D-fructofuranosil iiiononier units. The  phagocytic capacities of 
human peripheral blood polyniorphonuclear leukocytes (PMNs) for 
Staplrylororirrs aureus were evaluated in 20 healthy donors prior to and 
after treatinent with levan. The following forms of levan were used: 
mixtures of molecular masses (LM), separated high ~nolecular frac- 
tion (LA), and the synthesized compounds (LO, LOR,  LOH). 
Results: Treatnirnt of PMNs with levan 'it a concentr.ition of 
5 mg/nil stiniulated phagocytic capacity. LM c a u d  an iucrc;i\e in 
the atiiouiit of active leukocytes up to 13.Y-S0'%1 and phagocytic 
index up to 33.3-5 1.3% LO correspondingly X.3-h4.6'%1 and 
16.7-48.6'111, LOR 23.6-62.5'11, and 55.0-70.3%, aiid LOH 
9.9-64.6'%1 and 25.0-103.0%1. There was sirnultaneotisly iiicreajed 
activity of alkaline phosphatase dud nonspecific c\terase. There were 
differences in the activities of opsonic and non-opsonic. 
Conclusions: Treatment of human PMNs with differcnt form\ of 
phagocytos1s. 
the bactei-ial polysaccharide levaii activated phagocytic activity. 
1-1 IgG subclass deficiencies (IgG SCD) in adults 
with recurrent respiratory infections 
A. Lubasch, M. Rau, G. Schreiber, H. Lode. Dyarf i i ierr f  of C l m /  
and Iufictiuur Disenses. C i t y  Hiispital, Bcrlirr-%(~h/c~ridiiIf;~ ( crrnarry 
Objectives: The importance of 1gG subclass deficiencies in 'idult\ I S  
still uncertain. Therefore, further studies are necessary to clariFy the 
clinical relevance. 
Methods: Three hundred and twenty-five determination\ of IgG 
subclasses (1gG SC) in 279 patients with recurrent respiratory iufec- 
tions were studied froin 5 January 1993 to 1 0  Januxy 1908. The  IgG 
SC determinations were made by radial iniinunodifftisioii (RII)). 
Normal ranges of IgG SC were derived from 5th and 95th 
percentiles. Also IgG SC from 20 healthy subjects were determined 
as a control group. Values more than 2 SL) below thc uiean of the 
control gi-oup were classified as significant IgG SCI). 
Results: In 172 determinations, 52.9% of thc values of IgG S C  
were out of the normal ranges (62.2% below, 30.8'%$ above, and i n  
7% a coiiibination of increased and decreased IgG SC value\). We 
detected an 1gG SCl l  in 95 patients: 62 patients (65.2%) had a n  
isolated IgG SCD (IgGj SCD in 46.8%, 1gGz SCI) in l.fi'%,, IgGj 
SCD in 27.4% and IgG, SCD in 24.2%), and 33 patients (34.8%) a 
combined IgG SCI) (lgG13 SCD in 21.2'%1, lgG1+2 and IgC;r+, SCD 
in 12.1% each, 19(;12+1 and lgGI+j+q SCL) in 9.194 each, arid 
IgG2+2, IgGr+,, Ig(;,j+.~ I ~ G I + z + + ,  IgGz=I=d and IgGr+z+?+q S(:l) 
iii 6.1% each). A significant IgG SCL) was detected in 19 c ~ w s  in 
IgGi SC. and in 20 cases in IgGz SC and I U  27 cases we saw an IgGa 
SC value <0.03 g/L. The mean age in patients with IgG1 and  IgGr 
SCD is higher (53 and 61 years) than in patients with IgG, and IgGq 
SCD (44 atid 42 years). The niain diaposis in isolated and combined 
IgG, SCD is COP11 and asthma with recurrent infections. In isolated 
lgG4 SCD we saw pneumonia and bronchiectaw most frequently, 
and in isolated IgGj SClX COPII, asthma and pneumonia. 
Conclusions: Isolated IgG SCI) are more coninion in p.itieiitc 
with recurrent respiratory infections (65.2'%> versus 34.8'%1). Further 
studics and follow-up studies for patients with a \ignificatit IgC; SCl) 
are needed to clarify the clinical relevance 
1 PI 59 I Identification of pneumococcal proteins 
reactive with lgG derived from patients 
suffering from pneumococcal septicemia 
K.J.M. Bongaerts, G. Zysk, E. ten Thoren, H-P Hcinz I m t i f u f ~ f i r r  
Medirirrisclie Mikro(iio/itqic urrd I/irido,qic, Ilirivcrsirnt Dii.<se/dort; 
G(wnany  
Objectives: Identification of pneuinococcal proteins with potential 
as vaccine antigens. 
Methods: A genoniic expression libi-dry of a Srvqitorotrrrc pirtnrno- 
niae type 1 $train was screened by colony ~nimunoblot usuig a c0nv.1- 
lescence serum. Putative positive clones were further analyzed by 
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western blot analysis using the convalescence serum and positive 
clones were sequenced. 
Results: About three dozen distinct clones were reactive with IgG 
of the convalescence serum. Primary sequence analysis revealed that 
isolated gene fragments corresponded to genes encoding known 
pneumococcal proteins, such as neuraminidase A, fl-N-acetylhex- 
osaminidase, oligopeptide permeases, triosephosphate isomerase, and 
exodeoxyribonuclease VIi, and unknown pneumococcal genes. 
Among the latter are homologs to Bacillus subtilis genes encoding 
probable membrane proteins and unknown putative surface proteins 
containing a C-terminal LPXTG motif necessary for cell wall 
anchoring. 
Conclusions: Screening of a genomic expression library from S. 
pneumoniae with a convalescent serum revealed pneumococcal 
protein antigens which had been immunogenic during pneumococ- 
cal disease. Besides known proteins, new probable surface antigens 
have been identified which could be useful for vaccine development. 
Ip160] Rubella immunization: specificity and avidity of 
humoral response 
J. Nedeljkovic’, C. Oker-Blom2, S. Mladjenovic’, T. Jovanovic’. 
‘Institute-Torlak, Yugoslavia; VTT Biotechnology and Food Research, 
Finland’; Institute o f  Microbiolofy and Immunology, School o f  Medicine, 
University of Belgrade, Yupslavia 
Objectives: We have characterized the specificity of humoral 
immune responses to rubella virus (RV) after vaccination. 
Methods: Sera of 18 vaccinees (MORUPAR, R A  2713). aged 
12-24 months, obtained after 2 weeks and 1 and 24 months, and sera 
of 62 vaccinees, aged 9-14 years, obtained after 1, 2, 6 and 12 
months, were studied for the presence of anti-RV IgM, IgG, 1-11 
antibodies and anti-RV avidity. In some sera, the specificity and avid- 
ity of IgG antibodies for individual RV proteins (EI, E2 and C) were 
further examined with immunoblot assays with recombinant RV 
proteins as antigens. 
Results: Primary immune responses detected in 61 vaccinees 
were characterized with IgM responses and low-avidity IgG anti- 
bodies, appearing within 4 weeks. Immune response to EI protein 
was dominant. Prolonged maturation of IgG responses specific to 
whole virus correlated with maturation of anti-EI antibodies. Two 
persons failed to respond to RV vaccination and a few developed a 
transient response to EI protein after natural as well as after vaccinal 
RV infection. Children with specific immune responses before vacci- 
nation had a higher mean titer of antibodies before and after vacci- 
nation than did seronegative children. 
Conclusions: Determination of the specificity and avidity of IgG 
antibodies to individual RV proteins will contribute to better assess- 
ment of vaccine immunity protective value. 
I PI61 I Immune response in patients with 
tonsilloglandular form of tularemia 
M. Sainnaliev, M. Abugalia, K. Plochev, K. Mladenov. Milirary 
Medical Academy, S u ~ a ,  Bufgaria 
Objectives: To study the immune response of patients with tonsil- 
loglandular forms of tularemia. 
Methods: Flow cytometric analysis was used to reveal the changes 
of absolute counts and percentage of immune cells. Humoral 
immune reactions were estimated by immunodiffusion and serologic 
methods. 
Results: We studied the immune response of patients with the 
tonsilloglandular form of tularemia in an epidemic region 1-3 
months after they developed the disease. Flow cytometric analysis 
revealed increases in absolute count and percentage of T-cells (CD3). 
NK cells (CD16/CD56) and HLA-DR/CD3, but no significant 
variation in CD3/CD4+-CD3/CD8+ ratio, and B-cells (CD19). 
The levels of sera IgG, IgM and IgA were normal, but increases of 
complete complement and CD3/CD4 complements were found. 
CIC and haptoglobin titers were also increased in blood serum. 
Serologic estimation indicated agglutination titers in the range 1 :320 
to 1:640. The allergic reactions to Tularin were positive in all patients. 
The phagocytic cells in blood possessed high functional activity. 
Conclusions: These data suggest additional criteria for estimat- 
ing the post-infection status of the disease. 
[p1621 Use of herpetic vaccine for treatment of 
patients with relapsing herpetic infection 
V.M. Semyonov, N.F. Akulich, V.M. Kozin, T.I. Dmitrachenko. 
Vitebsk State Medical Institute, Mtebsk, Republic of Belarus 
Objectives: To evaluate the efficiency of herpetic vaccination in 
the treatment of patients with relapsing herpetic infection. 
Methods: We observed 146 patients with relapsing herpetic infec- 
tion aged from 10 to 74 years. Ninety of them were female and 56 
male. The duration of the disease did not exceed I year in 39.7% of 
patients, was 1-10 years in 47.9%, and was more than 10 years in 
12.4% The process was localized in the pudendal region in 65.8% of 
patients, and on the face in 18.5%; the mixed form ofthe dtsease was 
demonstrated in 15.7%. All the patients were inoculated with cultural 
herpetic vaccine, containing antigens of virus herpes simplex of types 
I and 11, in a volume of 0.2 L1 intracutaneously. 
Results: The results were assessed according to the absence of 
herpetic infection relapses or to the decrease in the frequency of 
relapses. AU the patients were divided into three groups according to 
the results of the vaccination: (1) the positive results were noted after 
the first course of vaccination-14.3% of patients; (2) the positive 
results were noted after the second course--67.7% (3) the positive 
results were noted after the third course-l8.4%. 
Conclusions: The results acquired allow us to recommend 
herpetic vaccination for the prevention of relapses caused by herpes 
simplex infection. 
. 
I P I  63 I Differential cytokine responses to challenge 
with live and killed Mycobacterium bovis 
(BCG) 
E.Valadas, S. Atkinson, H.M. Dockrell, LSHTM, Infect. and Eop. 
Diseases, London, UK 
Resistance to Mycobacterium tuberculosir is only efficiently generated 
with live but not with dead bacteria. This suggests that the antigens 
necessary to generate resistance are secreted by live and metabolically 
active bacteria but not by killed organisms. 
Objectives: To determine the patterns of cytokiiie production 
following peripheral blood mononuclear cell (PBMC) stimulation 
with live and killed (irradiated) M .  bovis BCG. 
Materials and methods: PBMCs were stimulated with live or 
killed M .  bovis BCG. Production of extra- and intracellular TNF- 
alpha and IL-10 was assayed. 
Results: There were significant differences in the ability of live 
and killed M .  bovis BCG to elicit TNF-alpha production, with live 
bacteria inducing greater TNF-alpha production. Although there was 
wide variability in the ability of individuals to produce TNF-alpha, 
overall increased levels of TNF-alpha were obtained when the live 
BCG preparation was used. 
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Conclusions: These results suggest that live bacteria secret anti- 
gens which induce TNF-alpha production by monocytes. 
Reactogenicity of whole cell (DPTw) and 
acellular (DPTa) pertussis-diphtheria-tetanus 
vaccine, administered at 2,4 and 6 months of 
age 
A. Gentile, C. Gil, N. Bidone, C. D'Anna, Hospital de N, R 
G i r t i ~ r r e z ,  Epideiniology, Bnunos A i m ,  Ayetitiria 
Objectives: To evaluate the reactogenicity of DPTw and DPTa 
administered at 2, 4 arid 6 months of age. 
Methods: During an 8-month period, 102 children presented 
spontaneously to the Immunization Clinic at the Kicardo Gutierrez 
Children's Hospital. According to the National Immunization 
Schedule. these children received either a four-component DPTa 
vaccine or DPTw vaccine. Within 7 days post-vaccination, local and 
systemic side effects were registered through an active follow-up 
system. 
Results: Sixty-nine (n=69) patients received DPTa and 33 
( ~ = 3 3 )  received DPTw. The  following side effects were observed: 
Local riwtiows: 
Erythema: DPTw 42.4%1, DPTa 13%) (p 0.001) 
Pain: DPTw 36.3%>, IIPTa 8.7% (p 0.0007) 
Swelling: DPTw 39.4'%, DPTa 14.5% (p 0.005) 
Warm: IIPTw 21.294, DPTa 7.2% (p 0.04) 
Systemic reactions: 
Fever: DPTw 24.2%, DPTa 5.8% (p 0.007) 
Anorexia: DPTw 33.394, DPTa 5.8% (p 0.0003) 
Fussiness: DPTw 57.6%1, DPTa 30.4% (p 0.001) 
Drowsincsr: DPTw 36.3%1, DPTa 15.9% (p 0.02) 
Conclusions: Significantly fewer vaccine-associated adverse 
effects were detected in children of 2, 4 and 6 months of age who 
received Dk'Td. 
rp1651 Pneumococcal vaccination by general 
practitioners: an evaluation of current practice 
W E .  Peetermans', I! Lacante'. 'Department of Internal Medicine, 
Uitivevsity Hospital, Leniw, 'Medical Department CVyeth Lederle, 
Loiri,flirt-l~-.~'eiivc, Bc[qiunz 
Objectives: To evaluate the use of the 23-valent pneumococcal 
vaccine during the first 2 years after its registration in Belgium and 
to asscss the profile of patients who receive the vaccine from their 
GI? 
Methods: Sales data on a monthly basis for 1996 and 1997 were 
provided by both vaccine manufacturers. Patient data was obtained 
on 10 consecutive vaccine recipients per GP  in 1996 and 1997. 
Results: The number? of vaccine doses were 166 and 211 per 
1 0  000 inhabitantc in  1996 and 1997, respectively. Up  to 85% of the 
vaccine doses wcre administered in September, October and 
November. Eighty-two per cent of the 18 236 study patients were 
above hi) years of age. The  main indications for vaccination were 
chronic bronchopulnionary dicease (41%) and cardiovascular disor- 
ders (2h'Xl). Age as the sole criterion was used in only 17% ofvaccine 
recipients. Sixty per cent of the patients received an influenza vaccine 
concoini tan tly 
Conclusions: A high vaccination coverage (20% of the targeted 
population) was reached during the first 2 years after registration of 
the pneunioccal vaccine in Belgium. GPc used the opportunity 
provided by the annual influenza vaccination to administer the pneu- 
inococcal vaccine concomitantly to patient? with chronic medical 
conditions. 
/p166\ Production of TNF and IL-1 by human 
peripheral blood monocvte-derived 
macrophages stimulated with different 
pneumococcal strains and their cell-free 
supernatants 
S. Uino, G. Whiting, J. Kaynes. LSHTM, I@cf. nprd Tropical Md., 
Londoti, UK 
Objectives: To evaluate the ability of encapsulated and unencaptu- 
lated pneuinococcal ctrains and their cell-free supernatants to induce 
T N F  and IL-1 release from human peripheral blood nionocyte 
(PBM)-derived macrophages. 
Methods: Pneumococcal clinical isolate serotypc 111 m d  unen- 
capsulated strain R36A were studied. The bacterial mpernatmts were 
collected during the log and stationary phases. After centrifugation, 
the wpernatants were filtered. The  bacteria were irradiated after 
colony-forming units per nil (CFU/mL) were deterniined. Human 
PBMc were isolated from bu@ coats of healthy volunteers u~ ing  
Histopaque 1077 and resuspended at 3x10' cells/niL in growth 
medium. After incubation for 5 days they were stimulated with irra- 
diated bacteria (102-10' CFU/niL) and their cell-free supernatants 
(0.005-0.3 mL/mL). LPS and mediuni were used ac positive and 
negative controls respectively. T N F  and IL-1 levels in cupernatants 
collected after 24 h of incubation were measured by ELISAS. 
Results: Serotype I11 stimulated higher release of T N F  
(4000f1350 pg/inL) than strain R36A (100t24  pg/mL). The 
supernatants of both bacteria collected at log phase did not cause 
T N F  production but the supernatants from the stationary phase 
induced high T N F  release by human PBM-derived macrophage\. 
Only serotype 111 caused a low release of IL-1 (225216 pg/niL). 
Conclusions: The presence of the capsule ic an important factor 
of pneumococcal strains for T N F  induction from human 
macrophages. The ability of the bacterial cell-free supernatants of the 
stationary phase to induce T N F  release from human macrophage\ is 
evidence of the role that certain products of autolysin cell wall degra- 
dation must have in cytokine release. 
Ip1671 Sequential immunization with IPV and OPV in 
infants 
H.H. Frayha, 0. Khatib, A. Abdulkarini, 2. Kafii, S. A1 Hajar, S. 
Farooqi, H. Tufenkeji, Bashir Khan. Kiri'q Faisal Specialist Hospital 
and Research Center, Riyadh, Saudi Arabia 
Objectives: To assess the safety and immunogenicity of two sched- 
ules ucing three doses of DTP-Hib (TetractHib) and oral poliovirus 
vaccine, or  two doses of IPV-IITP-Hib (PentactHib) followed by one 
dose each of TetractHib and oral poliovirus vaccine in infants. 
Methods: This prospective, randomized, double-blind study 
involved 168 healthy infants aged 6-8 weeks. Group 1 received OPV 
and TetractHib at 6, 12 and 20 month? of age; group II received 
PentactHib at 6 and 12 weeks and one dose each of TetractHib and 
OPV at 20 weeks of age. Additionally, all infants received BCG and 
hepatitis B vaccines. Seropositivity was evaluated for all vaccine anti- 
gens at study entry and 4-6 weeks after the third vaccination. 
Reactogenicity was evaluated after each vaccination with diary cardc 
and telephone questionnaire 
Results: There were no difference5 between the two groupc in 
age, gender, weight, or antibody titers at study entry, except for diph- 
theria. The adverse reactions to vaccines were not significantly differ- 
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ent. There were 69 paired sera from infants in group I and 63 6om 
group 11. The geometric mean titer (GMT) of antibody against 
polivirus was significantly higher in group I1 compared to group I. 
There was no difference in the GMT for prp and pertussis among 
the two groups; however, tetanus and diphtheria antibody levels were 
lower in group 11. The rate of seroprotection was comparable 
between the two groups for all vaccine antigens. The protective anti- 
body titers for poliovirus 1, 2 and 3 were 98.596, 100% and 98.5% 
respectively for group I, and 96.8%. 100% and 93.6% respectively for 
group 11. 
Conclusions: Sequential vaccination with IPV and OPV leads to 
high protective antibody levels. The clinical significance of decreased 
antibody titers of tetanus and diphtheria is not known. 
m1 Quorum-sensing blockers based on the 
Staphylococcus epidermidis agr pheromone 
M. Otto, R. SiiBmuth, C. Vuong, G. Jung, E Gotz. Universitdt 
Tiebingen, Mikrobielle Genetib, Tuebingen, Germany 
The agr quorum-sensing system in staphylococci controls the 
production of suriace proteins and exoproteins. In the pathogenic 
species Staphylococcus anreus, these proteins include many virulence 
factors. The extracellular signal of the quorum-sensing system is a 
modified peptide pheromone, whose sequence varies among the 
different staphylococcal strains. Previously we have shown that the 
modification in the S. epidermidis pheromone is a thiolactone struc- 
ture linking a central cysteine residue to the C-terminal carboxy 
group (Otto M, SiiRmuth R, Jung G, Gotz F. Structure of the 
pheromone peptide of the S. epidernridis agr system. FEBS Lett1998; 
424: 89-94). This structure is likely to be conserved in all staphylo- 
coccal agr pheromones. We demonstrate that a synthetic S. epider- 
midis pheromone is a competent inhibitor of the S. aureus agr system. 
Derivatives of the pheromone, in which the N-terminus or the cyclic 
bond structure was changed, were synthesized and their biological 
activity was determined. The presence of a correct N-terminus and 
a tholactone were prerequisites for an agr-activating effect in S. 
epidermidis, whereas inhibition of the S. anreus agr system was less 
dependent on the original structure. One derivative showed efficient 
repression of the S. aureus system, but had lost the ability to activate 
the S. epidermidis system. Our results show that effective quorum- 
sensing blockers that suppress the expression of virulence factors in 
S. aureus can be designed based on  the S. epidermidis pheromone. 
DNA as vaccine or therapeutic against cancer 
and viral infections 
K. Moelling, J. Pavlovic, J. Schultz, Th. Schuh, E. Obraschall, L. 
Heinzerling. Institute of Medical Virology of the University of Zurich, 
Zurich, Switzerland 
Plasrmd DNA encoding viral or tumor-associated antigens can 
induce protective immune responses against challenge with virus or 
tumor cells when the DNA is injected intramuscularly (Moelling K. 
J Mol Med 1997; 75: 2 4 2 4 ;  Moelling K. Cytokines Cell Mol Ther 
1997; 3: 127-36; Moelling K. Gene Ther 1998; 5: 573-4). We are 
developing a DNA vaccine against malignant melanoma with a 
tumor and a metastasis model in mice using a melanoma-associated 
antigen and a number of cytokine-encoding DNA plasmids such as 
IL-2, GM-CSF, IL-12, and the co-stimulator B 7.1. Depending on 
the type of cytokine, some tumor reduction was observed, while 
metastasis in the lung was strongly inhibited. Systemic expression of 
cytokines was monitored over time and was long-lasting. Nonspecific 
CpCs showed only transient efi>cts. The protective immune response 
is analyzed using various genetically altered mice such as perforin, 
interferon receptor (IFN-Ka), CD8+ cell and B-cell knockout mice. 
The mice were also immunized with viral DNA coding for influenza 
A hemagglutinin and nucleoprotein, HIV-1 gag-pol, NC, bunya viral 
antigens and CMV antigens. Combinations of viral antigen-encod- 
ing DNA with DNA encoding cytokines or peptides are under inves- 
tigation. 
New drugs 
m1 Methenamin hippurate in chronic relapsing 
pyelonephritis (CRP) 
LSilan, V Krcmery Jr'. G. Kovac', L. Langsadll, S. Nyulassy', J. 
Breza'. 'Derers Hospital, Department of Internal Medicine, Department 
of Clinical Biorhemistry, Department o f  Microbioloa and Immunology, 
Department o f  Urology, 'Pospaduate Medical School, Bratislava, Slovak 
Republic 
In a group of 84 patients (12 men and 72 women, aged 15-60) with 
CRP, the organotoxicity, metabolic changes, adverse effects and 
antibacterial activity of M-H in long-term treatment is reported. The 
drug was administered for 6-27 months in a 0.5-2-g dose with ascor- 
bic acid. N o  organotoxicity or immunotoxicity was established. A 
slight decrease of hemoglobin and an increase in the acidity of urine 
were demonstrated. No serious adverse effects appeared. A rapid 
decrease in the bacterial count in Enterobacteriaceae, Proteus, 
Klebsiella, Serratia, Pseudomonas species and microorganisms causing 
sexually transmitted diseases (Mycoplasma, Ureaplasma, Gardenerella, 
etc.) could be demonstrated. Prophylaxis with M-H can reduce the 
rate of relapses in patients suffering from C R P  from 3-6 per year to 
nearly 0 per year. After termination of the therapy, 80-85% of 
patients were relieved of symptoms for prolonged periods, and there 
were no long-term effects after termination of therapy for 60%. 
Long-term M-H therapy does not cause resistance of bacteria or 
selection of resistant mutants of gastrointestinal flora. Methenamin 
hippurate seems to be effective in the prevention of chronic 
pyelonephritis relapses. 
Ip172] Evaluation of antiviral activity of new 
benzimidazole derivatives 
G. Gentilomi', L. Garuti', M. Robert?, S. Venturoli', E. 
Manaresil, N.I. Zerbini', M. Musiani'. 'Department of Clinical and 
Experimental Medicine, Microbiology Section, 'Department of 
Pharmaceutical Science, University of Bologna, Italy 
The versatility of benzimidazole and its potential to yield derivatives 
with a wide range of biological activity has made it a useful structure 
for further molecular exploration. It is well known that several benz- 
imidazoles 1-rubstituted are antiviral agents and good inhibitors of 
R N A  viruses. In our study we evaluated the antiviral activity of a 
series of newly synthesized benzimidazole-N-carbamates. Consider- 
ing the importance of the substituents at position 2 of this heterocy- 
cle, we have introduced different groups. The choice of the chains 
linked at the C-2 was made in view of their presence in other classes 
of antiviral compounds. An amide group appeared in L-737,129; an 
ester function was crucial for activity in some aryl pyrrolyl sulfone 
